Shockwave Medical, Inc. Common Stock
SWAV
SWAV was delisted on the 30th of May, 2024.
240 hedge funds and large institutions have $6.11B invested in Shockwave Medical, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 56 funds opening new positions, 82 increasing their positions, 71 reducing their positions, and 33 closing their positions.
70% more first-time investments, than exits
New positions opened: 56 | Existing positions closed: 33
55% more call options, than puts
Call options by funds: $73.4M | Put options by funds: $47.4M
44% more capital invested
Capital invested by funds: $4.24B → $6.11B (+$1.87B)
15% more repeat investments, than reductions
Existing positions increased: 82 | Existing positions reduced: 71
11% more funds holding
Funds holding: 217 → 240 (+23)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$95.3M |
| 2 |
Barclays
London,
United Kingdom
|
+$31.1M |
| 3 |
Morgan Stanley
New York
|
+$30.9M |
| 4 |
BlackRock
New York
|
+$30M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$22.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$105M |
| 2 |
Millennium Management
New York
|
-$40.9M |
| 3 |
Wells Fargo
San Francisco,
California
|
-$40.7M |
| 4 |
Jennison Associates
New York
|
-$38.8M |
| 5 |
Holocene Advisors
New York
|
-$33.7M |
SWAV Hedge Fund Activity: Q2 2021 in Review
240 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Shockwave Medical, Inc. Common Stock (SWAV) for Q2 2021, worth a combined $6.11B — up 44% from $4.24B a quarter earlier.
Buyers outnumbered sellers: 56 funds opened new SWAV positions and 33 closed out — a net gain of 23 holders — while 82 added to existing stakes and 71 trimmed.
The largest buyer was Invesco, adding an estimated $95.3M. The largest seller was T. Rowe Price Associates, cutting an estimated $105M.
- 240 institutional investors held Shockwave Medical, Inc. Common Stock (SWAV) as of Q2 2021, up from 217 in Q1 2021.
- Funds reported $6.11B of Shockwave Medical, Inc. Common Stock stock for Q2 2021, up 44% quarter-over-quarter.
- 56 funds opened new Shockwave Medical, Inc. Common Stock positions in Q2 2021 and 33 closed out, a net change of +23 holders.
- The largest Shockwave Medical, Inc. Common Stock buyer in Q2 2021 was Invesco, an estimated $95.3M added.
- The largest Shockwave Medical, Inc. Common Stock seller in Q2 2021 was T. Rowe Price Associates, an estimated $105M sold.
Based on aggregated 13F filings for Q2 2021.